These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 18331662)

  • 21. In vitro alpha-glucosidase and alpha-amylase enzyme inhibitory effects of Andrographis paniculata extract and andrographolide.
    Subramanian R; Asmawi MZ; Sadikun A
    Acta Biochim Pol; 2008; 55(2):391-8. PubMed ID: 18511986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medical interventions in adolescent obesity.
    Khan UI; Collier M
    Adolesc Med State Art Rev; 2008 Dec; 19(3):406-20, viii. PubMed ID: 19227383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antihyperglycemic effects of total flavonoids from Polygonatum odoratum in STZ and alloxan-induced diabetic rats.
    Shu XS; Lv JH; Tao J; Li GM; Li HD; Ma N
    J Ethnopharmacol; 2009 Jul; 124(3):539-43. PubMed ID: 19454312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of live yeast culture supplementation on hindgut microbial communities and their polysaccharidase and glycoside hydrolase activities in horses fed a high-fiber or high-starch diet.
    Jouany JP; Medina B; Bertin G; Julliand V
    J Anim Sci; 2009 Sep; 87(9):2844-52. PubMed ID: 19465499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dietary supplements in the management of diabetes: potential risks and benefits.
    Geil P; Shane-McWhorter L
    J Am Diet Assoc; 2008 Apr; 108(4 Suppl 1):S59-65. PubMed ID: 18358258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 4-Hydroxyisoleucine: a plant-derived treatment for metabolic syndrome.
    Jetté L; Harvey L; Eugeni K; Levens N
    Curr Opin Investig Drugs; 2009 Apr; 10(4):353-8. PubMed ID: 19337956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bean amylase inhibitor and other carbohydrate absorption blockers: effects on diabesity and general health.
    Preuss HG
    J Am Coll Nutr; 2009 Jun; 28(3):266-76. PubMed ID: 20150600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plant lectins: potential antineoplastic drugs from bench to clinic.
    Liu B; Bian HJ; Bao JK
    Cancer Lett; 2010 Jan; 287(1):1-12. PubMed ID: 19487073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cetilistat, a new lipase inhibitor for the treatment of obesity.
    Padwal R
    Curr Opin Investig Drugs; 2008 Apr; 9(4):414-21. PubMed ID: 18393108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antidiabetic activities of Tecoma stans (L.) Juss. ex Kunth.
    Aguilar-Santamaría L; Ramírez G; Nicasio P; Alegría-Reyes C; Herrera-Arellano A
    J Ethnopharmacol; 2009 Jul; 124(2):284-8. PubMed ID: 19397980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of alpha-amylase and its inhibitors on acid production from cooked starch by oral streptococci.
    Aizawa S; Miyasawa-Hori H; Nakajo K; Washio J; Mayanagi H; Fukumoto S; Takahashi N
    Caries Res; 2009; 43(1):17-24. PubMed ID: 19136828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flavonoids for controlling starch digestion: structural requirements for inhibiting human alpha-amylase.
    Lo Piparo E; Scheib H; Frei N; Williamson G; Grigorov M; Chou CJ
    J Med Chem; 2008 Jun; 51(12):3555-61. PubMed ID: 18507367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natural compound renews hope for diabetes and obesity therapeutic target.
    Merk D; Schubert-Zsilavecz M
    Future Med Chem; 2015; 7(7):833-5. PubMed ID: 26061101
    [No Abstract]   [Full Text] [Related]  

  • 34. A critical review of the cannabinoid receptor as a drug target for obesity management.
    Akbas F; Gasteyger C; Sjödin A; Astrup A; Larsen TM
    Obes Rev; 2009 Jan; 10(1):58-67. PubMed ID: 18721231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cortex Lycii Radicis extracts improve insulin resistance and lipid metabolism in obese-diabetic rats.
    Ye Z; Huang Q; Ni HX; Wang D
    Phytother Res; 2008 Dec; 22(12):1665-70. PubMed ID: 19003954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The long-term influence of orlistat on dietary intake in obese subjects with components of metabolic syndrome.
    Svendsen M; Helgeland M; Tonstad S
    J Hum Nutr Diet; 2009 Feb; 22(1):55-63. PubMed ID: 19192027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of novel dual functional agent as PPARgamma agonist and 11beta-HSD1 inhibitor for the treatment of diabetes.
    Ye YL; Zhou Z; Zou HJ; Shen Y; Xu TF; Tang J; Yin HZ; Chen ML; Leng Y; Shen JH
    Bioorg Med Chem; 2009 Aug; 17(15):5722-32. PubMed ID: 19574056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Encapsulation of alpha-amylase into starch-based biomaterials: an enzymatic approach to tailor their degradation rate.
    Azevedo HS; Reis RL
    Acta Biomater; 2009 Oct; 5(8):3021-30. PubMed ID: 19427418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Red mold rice prevents the development of obesity, dyslipidemia and hyperinsulinemia induced by high-fat diet.
    Chen WP; Ho BY; Lee CL; Lee CH; Pan TM
    Int J Obes (Lond); 2008 Nov; 32(11):1694-704. PubMed ID: 18794894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PAR-5359, a well-balanced PPARalpha/gamma dual agonist, exhibits equivalent antidiabetic and hypolipidemic activities in vitro and in vivo.
    Kim MK; Chae YN; Son MH; Kim SH; Kim JK; Moon HS; Park CS; Bae MH; Kim E; Han T; Choi HH; Shin YA; Ahn BN; Lee CH; Lim JI; Shin CY
    Eur J Pharmacol; 2008 Oct; 595(1-3):119-25. PubMed ID: 18727927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.